Pharmaceuticals

Nanomaterials In Personalized Medicine Industry Overview 2025: Growth Projections and Market Trends

November 21, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Nanomaterials In Personalized Medicine Market?

The market size for nanomaterials in personalized medicine has expanded rapidly in recent years. It is projected to grow from $351.41 billion in 2024 to $392.97 billion in 2025, achieving a compound annual growth rate (CAGR) of 11.8%. This historical growth can be attributed to the increasing integration of nanotechnology in drug delivery, a rising demand for targeted therapies, greater awareness regarding the benefits of personalized medicine, an expansion of research into biomarker identification, and the growing prevalence of chronic diseases.

The nanomaterials in personalized medicine market is anticipated to show significant expansion over the next few years, set to reach $606.39 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.5%. This upward trajectory during the forecast period is fueled by factors such as the increasing demand for precision medicine, greater government investment in nanomedicine, a surge in partnerships between biotech and pharma firms, the growing use of advanced diagnostic technologies, and an intensified focus on patient-specific treatment approaches. Prominent developments expected in this period include ongoing technological improvements in nanoparticle design, the emergence of new nano-based drug formulations, innovations in targeted delivery systems, increased spending on research and development for personalized therapies, and the progression of hybrid nanomaterials for medical uses.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28276&type=smp

Which Drivers Are Shaping The Nanomaterials In Personalized Medicine Industry’s Market Share?

The rising need for individualized healthcare approaches is anticipated to fuel the expansion of the nanomaterials in personalized medicine market. Personalized medicine refers to a healthcare strategy where treatments are customized for patients considering their unique genetic, environmental, and lifestyle attributes to enhance results and patient care. This surge in demand is attributed to progress in genomic technologies, allowing for accurate detection of genetic differences and the development of specific therapies. Within this context, nanomaterials in personalized medicine improve personalized treatments by facilitating targeted and unique patient therapies, thus boosting effectiveness and safety. They facilitate the accurate delivery of drugs, genes, or RNA, minimizing adverse effects and maximizing therapeutic results. As an illustration, in February 2024, data from the Personalized Medicine Coalition (PMC), a US-based nonprofit, showed that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, marking a notable rise from the 12 approved in 2022. Consequently, the escalating demand for personalized medicine is serving as a key driver for the expansion of the nanomaterials in personalized medicine market.

What Are The Different Segment Classifications Within The Nanomaterials In Personalized Medicine Market?

The nanomaterials in personalized medicine market covered in this report is segmented as

1) By Type Of Nanomaterials: Carbon-Based Nanomaterials, Metallic Nanoparticles, Polymeric Nanomaterials, Nanostructured Materials, Silica Nanoparticles

2) By Formulation Type: Nanoparticles, Nanosuspensions, Nanoemulsions, Nanocrystals, Nanoformulations For Targeted Delivery

3) By Technology Utilized: Nanofabrication Techniques, Bioconjugation Methods, Surface Modification Techniques, Molecular Imaging Techniques, Nanotechnology-Based Screening Methods

4) By Application Areas: Drug Delivery Systems, Diagnostics And Imaging, Therapeutics, Regenerative Medicine, Vaccines

5) By End-Users: Hospitals And Clinics, Research Laboratories, Pharmaceutical Companies, Biotechnology Firms, Academic Institutions

Subsegments:

1) By Carbon-Based Nanomaterials: Fullerenes, Carbon Nanotubes, Graphene, Carbon Dots

2) By Metallic Nanoparticles: Gold Nanoparticles, Silver Nanoparticles, Iron Oxide Nanoparticles, Copper Nanoparticles

3) By Polymeric Nanomaterials: Dendrimers, Micelles, Polymeric Nanoparticles, Hydrogels

4) By Nanostructured Materials: Quantum Dots, Nanowires, Nanosheets, Nanorods

5) By Silica Nanoparticles: Mesoporous Silica Nanoparticles, Colloidal Silica Nanoparticles, Porous Silica Nanoparticles, Functionalized Silica Nanoparticles

Which Trends Are Impacting The Nanomaterials In Personalized Medicine Market?

Leading companies operating within the nanomaterials in personalized medicine market are primarily focused on implementing strategic collaborations to expedite clinical application, broaden therapeutic uses, and reduce the time to market, all while conforming to evolving regulatory benchmarks. Strategic collaborations are defined as partnerships where organizations or institutions pool their expertise and resources to accelerate innovation and expand possibilities in personalized medicine. As an illustration, in May 2025, Acuitas Therapeutics Inc., a biotechnology company based in Canada, partnered with Integrated DNA Technologies Inc., a US-based genomics solutions provider, to introduce a personalized CRISPR gene-editing therapy delivery system. This system, utilizing their lipid nanoparticles platform, successfully treated a single baby with a rare genetic disease, featuring accurately targeted CRISPR payloads, custom dose tuning, and swift custom formulation. This advancement accelerates unique, highly individualized treatments. It significantly improves therapeutic precision and patient outcomes, though it also introduces challenges in scalable manufacturing, stringent regulatory adaptation, and ultra-low-volume production.

Which Major Firms Are Strengthening Their Position In The Nanomaterials In Personalized Medicine Industry?

Major companies operating in the nanomaterials in personalized medicine market are Pfizer & Co. Inc., BASF SE, Sanofi S.A., The Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA Darmstadt Germany, Evonik Industries AG, Eisai Co. Ltd., TÜV Rheinland AG, OCSiAl S.A., American Elements Inc., Cour Pharmaceuticals Inc., Nanocomposix Inc., NoPo Nanotechnologies Private Limited, Matexcel Biotech Inc., OncoNano Medicine Inc., Molecular Rebar Design Inc., Cello Therapeutics Inc., Apurano Pharmaceuticals GmbH, SGN Nanopharma Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/nanomaterials-in-personalized-medicine-global-market-report

How Is Nanomaterials In Personalized Medicine Market Demand Varying Across Different Regions?

North America was the largest region in the nanomaterials in personalized medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in nanomaterials in personalized medicine report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Nanomaterials In Personalized Medicine Market Report:

https://www.thebusinessresearchcompany.com/customise?id=28276&type=smp

Browse Through More Reports Similar to the Global Nanomaterials In Personalized Medicine Market 2025, By The Business Research Company

Nanomaterials In Cosmetic And Personal Care Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nanomaterials-in-cosmetic-and-personal-care-global-market-report

Nanomedicine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nanomedicine-global-market-report

Healthcare Nanotechnology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/healthcare-nanotechnology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795